|
2025-02-18 |
2025-02-14 |
V
Vente
|
Berres Jennifer
SVP & Chief Human Res. Officer
Dirigeant
|
5 378
-25.9%
322,31
1 733 362 USD
|
5 378
-25.9%
|
322,31
|
1 733 362 USD
|
|
|
2025-02-18 |
2025-02-14 |
V
Vente
|
Berres Jennifer
SVP & Chief Human Res. Officer
Dirigeant
|
4 155
-16.7%
322,96
1 341 878 USD
|
4 155
-16.7%
|
322,96
|
1 341 878 USD
|
|
|
2024-11-18 |
2024-11-14 |
V
Vente
|
Whalen Kathleen M
SVP & Chief Ethics Officer
Dirigeant
|
1 474
-13.5%
357,99
527 677 USD
|
1 474
-13.5%
|
357,99
|
527 677 USD
|
|
|
2024-11-14 |
2024-11-14 |
V
Vente
|
Akdamar Erol R
Group President
Dirigeant
|
2 900
-29.8%
353,00
1 023 700 USD
|
2 900
-29.8%
|
353,00
|
1 023 700 USD
|
|
|
2024-11-14 |
2024-11-14 |
VP
Vente planifiée
|
Billington Phillip G
SVP-Internal Audit Services
Dirigeant
|
3 897
-6.9%
350,00
1 363 950 USD
|
3 897
-6.9%
|
350,00
|
1 363 950 USD
|
|
|
2024-09-12 |
2024-09-12 |
VP
Vente planifiée
|
Cuffe Michael S.
EVP and Chief Clinical Officer
Dirigeant
|
8 358
-22.0%
385,42
3 221 340 USD
|
8 358
-22.0%
|
385,42
|
3 221 340 USD
|
|
|
2024-07-31 |
2024-07-31 |
V
Vente
|
Whalen Kathleen M
SVP & Chief Ethics Officer
Dirigeant
|
2 987
-24.0%
363,51
1 085 804 USD
|
2 987
-24.0%
|
363,51
|
1 085 804 USD
|
|
|
2024-07-31 |
2024-07-29 |
V
Vente
|
Whalen Kathleen M
SVP & Chief Ethics Officer
Dirigeant
|
1 864
-13.0%
359,92
670 891 USD
|
1 864
-13.0%
|
359,92
|
670 891 USD
|
|
|
2024-07-31 |
2024-07-29 |
V
Vente
|
Reiner Deborah M
SVP - Mktg. & Communications
Dirigeant
|
3 314
-48.6%
359,96
1 192 914 USD
|
3 314
-48.6%
|
359,96
|
1 192 914 USD
|
|
|
2024-07-29 |
2024-07-29 |
V
Vente
|
Wyatt Christopher F.
SVP & Controller
Dirigeant
|
4 000
-9.0%
360,20
1 440 782 USD
|
4 000
-9.0%
|
360,20
|
1 440 782 USD
|
|
|
2024-07-29 |
2024-07-25 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
1 857
-9.5%
355,05
659 328 USD
|
1 857
-9.5%
|
355,05
|
659 328 USD
|
|
|
2024-05-20 |
2024-05-16 |
V
Vente
|
Whalen Kathleen M
SVP & Chief Ethics Officer
Dirigeant
|
3 204
-25.3%
326,30
1 045 465 USD
|
3 204
-25.3%
|
326,30
|
1 045 465 USD
|
|
|
2024-05-17 |
2024-05-15 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
1 863
-8.7%
326,18
607 673 USD
|
1 863
-8.7%
|
326,18
|
607 673 USD
|
|
|
2024-05-13 |
2024-05-09 |
V
Vente
|
Cohen Jeffrey E.
SVP-Government Relations
Dirigeant
|
1 650
-24.1%
313,00
516 450 USD
|
1 650
-24.1%
|
313,00
|
516 450 USD
|
|
|
2024-05-13 |
2024-05-09 |
V
Vente
|
Cuffe Michael S.
EVP and Chief Clinical Officer
Dirigeant
|
6 311
-17.6%
316,88
1 999 825 USD
|
6 311
-17.6%
|
316,88
|
1 999 825 USD
|
|
|
2024-05-08 |
2024-05-06 |
VP
Vente planifiée
|
Cuffe Michael S.
EVP and Chief Clinical Officer
Dirigeant
|
1 600
-4.5%
309,00
494 400 USD
|
1 600
-4.5%
|
309,00
|
494 400 USD
|
|
|
2024-05-06 |
2024-05-03 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
890
-4.0%
312,00
277 680 USD
|
890
-4.0%
|
312,00
|
277 680 USD
|
|
|
2024-05-06 |
2024-05-02 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
973
-4.2%
312,00
303 576 USD
|
973
-4.2%
|
312,00
|
303 576 USD
|
|
|
2024-03-20 |
2024-03-20 |
VP
Vente planifiée
|
Wasserman Chad J
SVP and CIO
Dirigeant
|
876
-35.7%
330,25
289 299 USD
|
876
-35.7%
|
330,25
|
289 299 USD
|
|
|
2024-03-20 |
2024-03-18 |
VP
Vente planifiée
|
Wasserman Chad J
SVP and CIO
Dirigeant
|
344
-12.3%
321,97
110 758 USD
|
344
-12.3%
|
321,97
|
110 758 USD
|
|
|
2024-02-13 |
2024-02-09 |
V
Vente
|
Whalen Kathleen M
SVP & Chief Ethics Officer
Dirigeant
|
4 262
-29.4%
306,21
1 305 074 USD
|
4 262
-29.4%
|
306,21
|
1 305 074 USD
|
|
|
2024-02-06 |
2024-02-06 |
V
Vente
|
RUTHERFORD BILL B
CFO and EVP
Dirigeant
|
6 000
-41.5%
310,63
1 863 780 USD
|
6 000
-41.5%
|
310,63
|
1 863 780 USD
|
|
|
2024-02-07 |
2024-02-05 |
V
Vente
|
Wyatt Christopher F.
SVP & Controller
Dirigeant
|
4 000
-9.7%
312,42
1 249 680 USD
|
4 000
-9.7%
|
312,42
|
1 249 680 USD
|
|
|
2024-02-06 |
2024-02-05 |
V
Vente
|
Mosier Sammie S
SVP & Chief Nurse Executive
Dirigeant
|
1 645
-17.7%
312,00
513 240 USD
|
1 645
-17.7%
|
312,00
|
513 240 USD
|
|
|
2024-02-06 |
2024-02-02 |
VP
Vente planifiée
|
Wasserman Chad J
SVP and CIO
Dirigeant
|
652
-69.2%
312,04
203 451 USD
|
652
-69.2%
|
312,04
|
203 451 USD
|
|
|
2024-02-02 |
2024-01-31 |
VP
Vente planifiée
|
Cuffe Michael S.
EVP and Chief Clinical Officer
Dirigeant
|
3 200
-11.4%
306,79
981 734 USD
|
3 200
-11.4%
|
306,79
|
981 734 USD
|
|
|
2024-02-02 |
2024-01-31 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
3 861
-19.5%
307,00
1 185 327 USD
|
3 861
-19.5%
|
307,00
|
1 185 327 USD
|
|
|
2023-08-16 |
2023-08-14 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
5 204
-20.8%
269,12
1 400 516 USD
|
5 204
-20.8%
|
269,12
|
1 400 516 USD
|
|
|
2023-08-15 |
2023-08-11 |
V
Vente
|
Cohen Jeffrey E.
SVP-Government Relations
Dirigeant
|
1 500
-25.4%
270,00
405 000 USD
|
1 500
-25.4%
|
270,00
|
405 000 USD
|
|
|
2023-08-07 |
2023-08-03 |
V
Vente
|
Whalen Kathleen M
SVP & Chief Ethics Officer
Dirigeant
|
2 916
-22.1%
270,00
787 320 USD
|
2 916
-22.1%
|
270,00
|
787 320 USD
|
|
|
2023-05-02 |
2023-04-28 |
V
Vente
|
Akdamar Erol R
Group President
Dirigeant
|
3 500
-7.6%
285,00
997 500 USD
|
3 500
-7.6%
|
285,00
|
997 500 USD
|
|
|
2023-05-02 |
2023-04-28 |
V
Vente
|
Cuffe Michael S.
EVP and Chief Clinical Officer
Dirigeant
|
12 556
-30.4%
284,44
3 571 396 USD
|
12 556
-30.4%
|
284,44
|
3 571 396 USD
|
|
|
2023-04-26 |
2023-04-24 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
4 473
-16.7%
288,38
1 289 913 USD
|
4 473
-16.7%
|
288,38
|
1 289 913 USD
|
|
|
2023-04-14 |
2023-04-14 |
VP
Vente planifiée
|
Paslick P. Martin
SVP and CIO
Dirigeant
|
2 687
-9.8%
275,00
738 925 USD
|
2 687
-9.8%
|
275,00
|
738 925 USD
|
|
|
2023-04-12 |
2023-04-10 |
VP
Vente planifiée
|
Paslick P. Martin
SVP and CIO
Dirigeant
|
2 539
-9.3%
270,00
685 530 USD
|
2 539
-9.3%
|
270,00
|
685 530 USD
|
|
|
2023-04-06 |
2023-04-04 |
VP
Vente planifiée
|
Paslick P. Martin
SVP and CIO
Dirigeant
|
3 034
-11.0%
265,00
804 010 USD
|
3 034
-11.0%
|
265,00
|
804 010 USD
|
|
|
2023-02-22 |
2023-02-17 |
V
Vente
|
Whalen Kathleen M
SVP & Chief Ethics Officer
Dirigeant
|
1 734
-14.8%
263,61
457 097 USD
|
1 734
-14.8%
|
263,61
|
457 097 USD
|
|
|
2023-02-09 |
2023-02-07 |
V
Vente
|
Berres Jennifer
SVP & Chief Human Res. Officer
Dirigeant
|
4 000
-35.1%
255,23
1 020 912 USD
|
4 000
-35.1%
|
255,23
|
1 020 912 USD
|
|
|
2023-02-07 |
2023-02-03 |
V
Vente
|
Reiner Deborah M
SVP - Mktg. & Communications
Dirigeant
|
7 941
-100.0%
257,61
2 045 699 USD
|
7 941
-100.0%
|
257,61
|
2 045 699 USD
|
|
|
2023-02-03 |
2023-02-03 |
V
Vente
|
RUTHERFORD BILL B
CFO and EVP
Dirigeant
|
30 000
-26.9%
258,19
7 745 568 USD
|
30 000
-26.9%
|
258,19
|
7 745 568 USD
|
|
|
2023-02-06 |
2023-02-02 |
V
Vente
|
Akdamar Erol R
Group President
Dirigeant
|
3 000
-8.0%
258,63
775 891 USD
|
3 000
-8.0%
|
258,63
|
775 891 USD
|
|
|
2023-02-01 |
2023-02-01 |
V
Vente
|
Paslick P. Martin
SVP and CIO
Dirigeant
|
1 000
-25.0%
256,95
256 949 USD
|
1 000
-25.0%
|
256,95
|
256 949 USD
|
|
|
2023-02-01 |
2023-02-01 |
V
Vente
|
Wyatt Christopher F.
SVP & Controller
Dirigeant
|
4 900
-13.1%
253,30
1 241 170 USD
|
4 900
-13.1%
|
253,30
|
1 241 170 USD
|
|
|
2023-02-01 |
2023-02-01 |
V
Vente
|
Foster Jon M
EVP and COO
Dirigeant
|
16 424
-60.0%
251,98
4 138 480 USD
|
16 424
-60.0%
|
251,98
|
4 138 480 USD
|
|
|
2023-02-01 |
2023-02-01 |
VP
Vente planifiée
|
Cuffe Michael S.
EVP and Chief Clinical Officer
Dirigeant
|
4 000
-16.1%
257,11
1 028 440 USD
|
4 000
-16.1%
|
257,11
|
1 028 440 USD
|
|
|
2023-02-01 |
2023-01-30 |
V
Vente
|
McManus Timothy M
Group President
Dirigeant
|
100
-0.7%
254,60
25 460 USD
|
100
-0.7%
|
254,60
|
25 460 USD
|
|
|
2023-02-01 |
2023-01-30 |
V
Vente
|
McManus Timothy M
Group President
Dirigeant
|
7 800
-35.6%
254,05
1 981 607 USD
|
7 800
-35.6%
|
254,05
|
1 981 607 USD
|
|
|
2022-11-15 |
2022-11-11 |
V
Vente
|
MOORE A BRUCE JR
Group President - Service Line
Dirigeant
|
10 000
-24.5%
224,07
2 240 690 USD
|
10 000
-24.5%
|
224,07
|
2 240 690 USD
|
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
Hall Charles J
Group President
Dirigeant
|
9 838
-4.7%
223,50
2 198 793 USD
|
9 838
-4.7%
|
223,50
|
2 198 793 USD
|
|
|
2022-11-01 |
2022-10-28 |
V
Vente
|
Sowell Joseph A III
SVP; Chief Development Officer
Dirigeant
|
12 946
-100.0%
223,18
2 889 304 USD
|
12 946
-100.0%
|
223,18
|
2 889 304 USD
|
|
|
2022-10-28 |
2022-10-28 |
VP
Vente planifiée
|
Billington Phillip G
SVP-Internal Audit Services
Dirigeant
|
8 332
-17.0%
222,58
1 854 518 USD
|
8 332
-17.0%
|
222,58
|
1 854 518 USD
|
|
|
2022-10-26 |
2022-10-24 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
300
-1.5%
209,94
62 982 USD
|
300
-1.5%
|
209,94
|
62 982 USD
|
|
|
2022-10-26 |
2022-10-24 |
V
Vente
|
Torres Kathryn A.
SVP-Payer Contracting & Align.
Dirigeant
|
1 700
-7.6%
202,13
343 623 USD
|
1 700
-7.6%
|
202,13
|
343 623 USD
|
|
|
2022-07-27 |
2022-07-25 |
A
Achat
|
Elcan Patricia F
Actionnaire important
|
325
+0.4%
198,66
64 565 USD
|
325
+0.4%
|
198,66
|
64 565 USD
|
|
|
2022-05-17 |
2022-05-13 |
V
Vente
|
Berres Jennifer
SVP & Chief Human Res. Officer
Dirigeant
|
2 358
-17.1%
218,87
516 086 USD
|
2 358
-17.1%
|
218,87
|
516 086 USD
|
|
|
2022-05-05 |
2022-05-03 |
V
Vente
|
Whalen Kathleen M
SVP & Chief Ethics Officer
Dirigeant
|
500
-4.2%
215,38
107 690 USD
|
500
-4.2%
|
215,38
|
107 690 USD
|
|
|
2022-05-04 |
2022-05-02 |
A
Achat
|
FRIST THOMAS F JR
Actionnaire important
|
7 577
+1.6%
215,29
1 631 279 USD
|
7 577
+1.6%
|
215,29
|
1 631 279 USD
|
|
|
2022-05-04 |
2022-05-02 |
A
Achat
|
FRIST THOMAS F JR
Actionnaire important
|
12 170
+2.7%
214,48
2 610 270 USD
|
12 170
+2.7%
|
214,48
|
2 610 270 USD
|
|
|
2022-05-04 |
2022-05-02 |
A
Achat
|
FRIST THOMAS F JR
Actionnaire important
|
7 683
+1.7%
213,47
1 640 067 USD
|
7 683
+1.7%
|
213,47
|
1 640 067 USD
|
|
|
2022-05-04 |
2022-05-02 |
A
Achat
|
FRIST THOMAS F JR
Actionnaire important
|
3 606
+0.8%
212,60
766 632 USD
|
3 606
+0.8%
|
212,60
|
766 632 USD
|
|
|
2022-05-04 |
2022-05-02 |
A
Achat
|
FRIST THOMAS F JR
Actionnaire important
|
16 313
+3.8%
211,22
3 445 589 USD
|
16 313
+3.8%
|
211,22
|
3 445 589 USD
|
|
|
2022-05-04 |
2022-05-02 |
A
Achat
|
FRIST THOMAS F JR
Actionnaire important
|
37 623
+9.5%
210,60
7 923 404 USD
|
37 623
+9.5%
|
210,60
|
7 923 404 USD
|
|
|
2022-05-04 |
2022-05-02 |
A
Achat
|
FRIST THOMAS F JR
Actionnaire important
|
4 128
+1.1%
209,73
865 760 USD
|
4 128
+1.1%
|
209,73
|
865 760 USD
|
|
|
2022-05-03 |
2022-04-29 |
A
Achat
|
McAlevey Michael R
SVP & Chief Legal Officer
Dirigeant
|
1 110
+inf%
218,56
242 602 USD
|
1 110
+inf%
|
218,56
|
242 602 USD
|
|
|
2022-05-02 |
2022-04-28 |
A
Achat
|
Smith Andrea B
Administrateur non-exécutif
|
1 160
+107.5%
213,63
247 815 USD
|
1 160
+107.5%
|
213,63
|
247 815 USD
|
|
|
2022-03-15 |
2022-03-11 |
VP
Vente planifiée
|
Sowell Joseph A III
SVP; Chief Development Officer
Dirigeant
|
11 522
-40.3%
269,00
3 099 418 USD
|
11 522
-40.3%
|
269,00
|
3 099 418 USD
|
|
|
2022-02-18 |
2022-02-17 |
V
Vente
|
MOORE A BRUCE JR
Group President - Service Line
Dirigeant
|
9 367
-9.3%
253,18
2 371 502 USD
|
9 367
-9.3%
|
253,18
|
2 371 502 USD
|
|
|
2022-02-18 |
2022-02-16 |
V
Vente
|
MOORE A BRUCE JR
Group President - Service Line
Dirigeant
|
20 633
-16.9%
244,01
5 034 685 USD
|
20 633
-16.9%
|
244,01
|
5 034 685 USD
|
|
|
2022-01-06 |
2022-01-04 |
VP
Vente planifiée
|
Sowell Joseph A III
SVP; Chief Development Officer
Dirigeant
|
22 198
-64.2%
259,23
5 754 390 USD
|
22 198
-64.2%
|
259,23
|
5 754 390 USD
|
|
|
2021-11-12 |
2021-11-11 |
V
Vente
|
Foster Jon M
Group President
Dirigeant
|
294
-100.0%
242,79
71 379 USD
|
294
-100.0%
|
242,79
|
71 379 USD
|
|
|
2021-11-12 |
2021-11-11 |
V
Vente
|
Foster Jon M
Group President
Dirigeant
|
7 000
-96.0%
242,20
1 695 394 USD
|
7 000
-96.0%
|
242,20
|
1 695 394 USD
|
|
|
2021-11-12 |
2021-11-11 |
V
Vente
|
Foster Jon M
Group President
Dirigeant
|
9 000
-55.2%
241,17
2 170 526 USD
|
9 000
-55.2%
|
241,17
|
2 170 526 USD
|
|
|
2021-11-12 |
2021-11-10 |
V
Vente
|
Reiner Deborah M
SVP - Mktg. & Communications
Dirigeant
|
2 052
-31.2%
246,23
505 261 USD
|
2 052
-31.2%
|
246,23
|
505 261 USD
|
|
|
2021-11-10 |
2021-11-10 |
VP
Vente planifiée
|
Billington Phillip G
SVP-Internal Audit Services
Dirigeant
|
8 252
-18.2%
246,26
2 032 096 USD
|
8 252
-18.2%
|
246,26
|
2 032 096 USD
|
|
|
2021-11-12 |
2021-11-09 |
V
Vente
|
Englebright Jane D.
SVP and Chief Nursing Officer
Dirigeant
|
3 364
-100.0%
249,61
839 689 USD
|
3 364
-100.0%
|
249,61
|
839 689 USD
|
|
